Y-Intercept (HK)’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$645K Buy
8,457
+947
+13% +$72.5K 0.01% 1233
2026
Q1
$607K Sell
7,510
-23,202
-76% -$1.93M 0.01% 1211
2025
Q4
$2.35M Buy
+30,712
New +$2.36M 0.05% 549
2025
Q3
Sell
-33,629
Closed -$2.36M 1878
2025
Q2
$2.36M Buy
+33,629
New +$2.46M 0.06% 525
2023
Q1
Sell
-14,408
Closed -$752K 1420
2022
Q4
$752K Buy
+14,408
New +$790K 0.11% 287
2021
Q4
Sell
-4,611
Closed -$247K 781
2021
Q3
$247K Buy
+4,611
New +$288K 0.04% 529

Other funds holding NHI

Y-Intercept (HK)'s NHI Position: Q2 2026 in Review

Y-Intercept (HK) increased its National Health Investors (NHI) stake by 13% in Q2 2026, buying an estimated $72.5K and bringing the position to 8,457 shares worth $645K. The position accounts for 0.01% of the portfolio, ranked #1233.

Y-Intercept (HK) first reported a position in NHI in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.36M in Q2 2025. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Y-Intercept (HK) held 8,457 shares of National Health Investors worth $645K as of Q2 2026.
  • Y-Intercept (HK) bought 947 National Health Investors shares in Q2 2026, an estimated $72.5K.
  • National Health Investors made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1233 holding.
  • Y-Intercept (HK) first reported a position in National Health Investors in Q3 2021 and has held it in 6 quarters since.
  • Y-Intercept (HK)'s National Health Investors position peaked at $2.36M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.